Kyeong Lee, PhD
Affiliations: | Pharmacy | Dongguk University, Seoul, South Korea |
Google:
"Kyeong Lee"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Kenneth A. Jacobson | post-doc | 2000-2001 | NIDDK, National Institutes of Health |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Elkamhawy A, Paik S, Ali EMH, et al. (2022) Identification of Novel Aryl Carboxamide Derivatives as Death-Associated Protein Kinase 1 (DAPK1) Inhibitors with Anti-Proliferative Activities: Design, Synthesis, In Vitro, and In Silico Biological Studies. Pharmaceuticals (Basel, Switzerland). 15 |
| Jacobson KA, Kim HS, Ravi G, et al. (2022) Engineering of A Adenosine and P2Y Nucleotide Receptors and Their Ligands. Drug Development Research. 58: 330-339 |
| Nada H, Lee K, Gotina L, et al. (2022) Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches. Computers in Biology and Medicine. 142: 105217 |
| Lee K, Nada H, Byun HJ, et al. (2021) Hit Identification of a Novel Quinazoline Sulfonamide as a Promising EphB3 Inhibitor: Design, Virtual Combinatorial Library, Synthesis, Biological Evaluation, and Docking Simulation Studies. Pharmaceuticals (Basel, Switzerland). 14 |
| Elsherbeny MH, Kim J, Gouda NA, et al. (2021) Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress. Antioxidants (Basel, Switzerland). 10 |
| Elkamhawy A, Woo J, Gouda NA, et al. (2021) Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress. Antioxidants (Basel, Switzerland). 10 |
| Elsherbeny MH, Elkamhawy A, Nada H, et al. (2021) Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity. Biomedicines. 9 |
| Elkamhawy A, Kim HJ, Elsherbeny MH, et al. (2021) Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action. Bioorganic Chemistry. 116: 105352 |
| Elkamhawy A, Ammar UM, Paik S, et al. (2021) Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening. Molecules (Basel, Switzerland). 26 |
| Elkamhawy A, Paik S, Park JH, et al. (2021) Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies. Bioorganic Chemistry. 115: 105233 |